Novartis decides not to make offer to acquire Berna Biotech

12-Jan-2006

After completion of due diligence and an assessment of the potential benefits and risks of an acquisition, Novartis has decided not to make an offer for Berna Biotech AG.

Novartis announced in December that it was considering whether to acquire Berna Biotech AG after Crucell N.V. made an offer earlier in December to acquire the Swiss company through an all-share exchange offer.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!